Health
Pharma boss: Incentives based on outcomes will optimise EU healthcare
An outcomes-based approach for incentives in the pharmaceutical sector would help optimise the entire healthcare systems, Nathalie Moll told EURACTIV.com in an interview.
EFSA boss: EU food law overhaul ‘a big step towards transparency’
The European Commission has learned its lesson from the glyphosate controversy and is coming forward with “bold proposals” on transparency, says Bernhard Url. The raw data of all industry-funded studies related to pesticides will be made publicly available under Commission plans, he told EURACTIV in an interview.
ECDC chief: Bigger social media presence needed to fight anti-vaccines fake news
Public health authorities at EU and national level have started working to “occupy more of the space on social media”, as it is currently almost entirely taken up by people who are against vaccination, Dr Andrea Ammon told EURACTIV.com in an interview.
Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation
The generic industry’s request for an SPC (supplementary protection certificates) manufacturing waiver, which would allow them to produce in the EU SPC-protected drugs for other markets, does not influence or harm innovators’ rights, Marc–Alexander Mahl told EURACTIV.com in an interview. He...
Pernod Ricard CEO: Alcohol tax ‘penalises’ responsible consumers
The decision to raise excise taxes on alcohol “penalises” the majority of consumers who drink responsibly, while those who have issues with alcohol will be unaffected as they will keep on drinking excessively, Alexandre Ricard told EURACTIV.com in an interview.
Energy poverty chair: Extreme summer heat could provide wake-up call
Two out of three EU countries do not measure energy poverty but a new observatory launched on Monday (29 January) should provide member states with the information they need to address a problem that could affect more than 100 million people in Europe, says the chair of the EU's Energy Poverty Observatory.
Health expert: Europe should not put its dominant pharma innovation at risk
The European Union should not create an environment more favourable to generics compared to the innovative pharmaceuticals, as it risks weakening Europe’s overall global strength in pharmaceuticals and in research, Professor Adrian Towse told EURACTIV.com in an interview.
Julie Girling MEP: ‘Most of us look for evidence that supports our own opinions’
When coming up with policy, EU officials and lawmakers have a variety of sources to call upon for scientific advice. But how useful is the information and how effective is the system in place? Julie Girling explained how she uses evidence in her day-to-day life as an MEP.
UN Environment chief: We shouldn’t wait for the oceans to turn into a plastic swamp
At the latest United Nations environment summit, pollution topped the agenda. The man leading the UN’s quest to clean up the planet hopes this meeting will act as the wake-up call countries need and that the fight will include the world of business.
Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped
Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive frameworks alive and well, Mark Alles told EURACTIV.com in an interview.
Patients’ leader: Reimbursed anti-smoking programmes are a way to kill COPD
Stricter rules on smoking, reimbursed anti-smoking programmes and smoke-free public places are among the ways to prevent chronic obstructive pulmonary disease (COPD) from being a public health crisis, says Mikaela Odemyr.
Kadenbach MEP: Tobacco warnings should mention chronic obstructive pulmonary disease
Progress has been made on tobacco products health warnings but the next round of graphic labelling should also mention the less-known chronic obstructive pulmonary disease (COPD), which happens to be the second cause of death worldwide, MEP Karin Kadenbach told EURACTIV.com.
Vaccines boss: Clear privacy rules are needed for electronic immunisation record system
An electronic immunisation record system, which aims to better monitor vaccination among populations, will need clear privacy rules and individuals should be the owners of their own data, Patricia Massetti told EURACTIV.com in an interview. Patricia Massetti is an associate...
Pharma boss: Targeting drugs won’t make healthcare systems more sustainable
“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation
Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business and patients must be part of the discussion as well as “innovation” because access would not get the focus it needs without it, according to Dorli Kahr-Gottlieb.
Food expert: There is a link between poverty and unhealthy diets
Working class people are being harmed as companies abandon free lunch programs, according to food and health policy expert Dr Martin Caraher.
Greek minister: EMA bid shows drugs are a social good
Athens’ decision to claim the European Medicine Agency's relocation from London sends a message that medicine is “not just a commodity but a social good”, Greece’s Alternate Minister of Foreign Affairs, Georgios Katrougalos, told EURACTIV.com.
Anti-monopolies economist: ‘Innovation breeds inequality’
Inequality is an inevitable side effect of innovation and many monopolies could be broken by simply eliminating patents, insists Italian economist Michele Boldrin. EURACTIV’s partner El País – Planeta Futuro reports.
Macron: Germany is competitive thanks to eurozone weaknesses
Ahead of Thursday’s (13 July) Franco-German Ministerial Council, Friday’s Bastille Day celebrations and Donald Trump’s visit to Paris, President Emmanuel Macron spoke to EURACTIV’s partner Ouest-France about Europe's future, and France’s relations with the US.
Endocrine disruptors: EU definition contains ‘too many exemptions and loopholes’
After years in the pipeline, an EU-wide definition of endocrine disruptors was finally approved by member states on 4 July. But MEP Pascal Durand told EURACTIV’s partner Ouest-France he is concerned the definition does not respect the precautionary principle.
Dutch health minister: EMA relocation is not entertainment, listen to the Commission
The European Medicines Agency (EMA) is not a toy to be played with by politicians, Edith Schippers told EURACTIV.com. The decision on the agency's relocation should be based on the European Commission's assessment, she argues in an interview.
Pharma expert: EU drug agency should be ‘easily’ accessible to all
Any country that wants to inherit the European Medicines Agency (EMA) from London has to be easily accessible. Candidates will also need to increase their national agency’s resources, as staff are expected to move to the EMA, according to Adrian van den Hoven.
Mimica: We are analysing aid funding gaps left by the US
The EU is analysing the aid funding gap left by Donald Trump’s decision to ban US federal funding for NGOs providing birth control support or abortions in developing countries, Development Commissioner Neven Mimica told EURACTIV.com in an exclusive interview.